Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification

Clinical trial NCT02177175 · COMPLETED

Trial details

NCT number

NCT02177175

Sponsor

Memorial Sloan Kettering Cancer Center

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-06-24

Primary completion

2021-06-24

Enrollment

82

View on ClinicalTrials.gov